Velcade and Antivert drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Velcade (bortezomib) and Antivert (meclizine hydrochloride). Common drug interactions include haematochezia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Velcade and Antivert. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Velcade?

Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 66,422 Velcade users. Check the latest studies of Velcade.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.



On Jul, 12, 2026

32 people who take Velcade and Antivert together, and have interactions are studied.

Velcade and Antivert drug interactions.

What are the common drug interactions of Velcade and Antivert, by gender? *:

female:

  1. Haematochezia (passage of stools containing blood)
  2. Amyloidosis (a tumour within which amyloid is produced)
  3. Cough
  4. Neuropathy peripheral (surface nerve damage)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Tinnitus (a ringing in the ears)
  7. Aspartate aminotransferase increased
  8. Asthenia (weakness)
  9. Dehydration (dryness resulting from the removal of water)
  10. Drug ineffective

male:

  1. Asthenia (weakness)
  2. Dehydration (dryness resulting from the removal of water)
  3. Cardiomyopathy (weakening of the heart muscle)
  4. Cyst (a closed sac)
  5. Cytomegalovirus infection
  6. Decreased interest
  7. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Diarrhoea
  10. Duodenitis (inflammation of the duodenum)

What are the common drug interactions of Velcade and Antivert, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Neuropathy peripheral (surface nerve damage)
  2. Ocular hyperaemia (an abnormally large amount of blood in eye)
  3. Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
  4. Oropharyngeal pain
  5. Osteolysis (dissolution of bone)
  6. Osteonecrosis (death of bone)
  7. Osteonecrosis of jaw (death of bone of jaw)
  8. Osteoporosis (bones weak and more likely to break)
  9. Osteoradionecrosis (irradiation of bones causes damage to osteocytes and impairs the blood supply)
  10. Pain

50-59:

  1. Aspartate aminotransferase increased
  2. Cellulitis (infection under the skin)
  3. Depression
  4. Gastrointestinal necrosis (destruction of gastrointestinal organ)
  5. Haemorrhage (bleeding)
  6. Hypertension (high blood pressure)
  7. Large intestine perforation (hole in large intestine)
  8. Pancreatitis acute (sudden inflammation of pancreas)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Suicidal behaviour

60+:

  1. Asthenia (weakness)
  2. Haematochezia (passage of stools containing blood)
  3. Bladder transitional cell carcinoma (types of bladder cancer)
  4. Blood creatinine increased
  5. Blood pressure systolic increased
  6. Body temperature decreased
  7. Chills (felling of cold)
  8. Colitis (inflammation of colon)
  9. Constipation
  10. Depression

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 7 people, 21.88%
  2. Pain: 4 people, 12.50%
  3. High Blood Pressure: 4 people, 12.50%
  4. Nausea And Vomiting: 4 people, 12.50%
  5. Urinary Tract Infection: 3 people, 9.38%
  6. Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 3 people, 9.38%
  7. Cancer Pain: 3 people, 9.38%
  8. Cardiac Disorder: 3 people, 9.38%
  9. Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 3 people, 9.38%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Velcade and Antivert?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Velcade and Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Velcade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Velcade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on bortezomib and meclizine hydrochloride (the active ingredients of Velcade and Antivert, respectively), and Velcade and Antivert (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: